Safety of Intravenous Thrombolysis for Wake-up Stroke "Wake-Up Stroke"


Phase 2 Results

Summary of Purpose

The purpose is to demonstrate the safety of intravenous tissue plasminogen activator (IV t-PA) in ischemic stroke patients who present to the emergency department (ED) after awakening with the symptoms of suspected ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 24 November 2014.

1 Jul 2010 16 Aug 2010 1 Oct 2013 1 Jan 2014 1 Nov 2014 28 Oct 2014
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Single Group Assignment